Berg S, Dehlin O, Falkheden T, Gatzinska R, Nordqvist P
Scand J Soc Med Suppl. 1977;14:85-96.
The hypnotic effect of dixyrazine (a phenothiazine derivate), nitrazepam and amylobarbitone was studied during six months in 52 geriatric inpatients (17, 16 and 19 in each group, respectively) with a mean age of 78 years. The variables registered were the percentage of patients asleep at 10 pm and 6 am and the observed number of awakenings. Certain mental and somatic variables were rated according to a schedule for geriatric behaviour. The observations were made every two to three weeks. No systematic significant change with time was observed for any of the three drugs for the percentage of patients asleep at 10 pm or 6 am or for the number of awakenings. Nor was any difference found between the three drugs in respect of these variables. There was no significant change in somatic or mental variables according to the geriatric rating schedule. The results indicate that dixyrazine, nitrazepam and amylobarbitone retain their hypnotic effect in geriatric patients during continuous use for a six-month period. No side effects were observed that influenced the patient' behaviour. The results do not support the view that barbiturates, i.e. amylobarbitone are inappropriate as hypnotics in the elderly patient.
对52名平均年龄78岁的老年住院患者(每组分别为17名、16名和19名)进行了为期6个月的研究,观察了二苯拉嗪(一种吩噻嗪衍生物)、硝西泮和异戊巴比妥的催眠效果。记录的变量包括晚上10点和早上6点入睡患者的百分比以及观察到的觉醒次数。根据老年行为量表对某些精神和躯体变量进行评分。每两到三周进行一次观察。对于这三种药物中的任何一种,晚上10点或早上6点入睡患者的百分比或觉醒次数均未观察到随时间的系统性显著变化。在这些变量方面,三种药物之间也未发现差异。根据老年评分量表,躯体或精神变量没有显著变化。结果表明,二苯拉嗪、硝西泮和异戊巴比妥在老年患者连续使用6个月期间仍保持其催眠效果。未观察到影响患者行为的副作用。结果不支持巴比妥类药物(即异戊巴比妥)不适用于老年患者作为催眠药的观点。